Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Spirometry screening in the community: is this an effective way of diagnosing early COPD? Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Case-finding for COPD: Developing strategies to identify patients at risk populations Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Impact of the nutritional status on pulmonary function in COPD patients Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Does satisfaction with inhaled asthma treatment correspond with spirometric parameters? Source: Eur Respir J 2006; 28: Suppl. 50, 501s Year: 2006
COPD exacerbations and adherence to treatment improvement:what goal can be achieved? Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
Justification for statistical process control in daily home spirometry for COPD patients Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013
Relationships between COPD assessment test score and pulmonary function tests or quantitative CT analysis in Japanese COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Adherence to home spirometry among patients with IPF: results from the INMARK trial Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Dynamic hyperinflation after bronchial lung volume reduction: An expected effect or perhaps a preoperative test for selection? Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
GLISTEN Study subanalysis: Glycopyrronium differentially improves lung function, health status and rescue medication use when added to salmeterol/fluticasone in COPD severity groups Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
The relevance of lung function tests in an intensive smoking cessation program Source: Annual Congress 2013 –E-cigarettes, shisha, the tobacco industry and public health Year: 2013
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015